DICER1 and breast carcinoma: Research has indicated that low Dicer expression is strongly interrelated with poor survival outcomes in hepatocellular carcinoma (HCC) [14], breast cancer [15], and cervical cancer [16] and that Dicer is involved in the regulation of chemotherapy sensitivity chemotherapy.